announces Archives

Enclara Pharmacia Announces the Appointment of Mark Morse as CEO

October 14, 2020

Enclara Pharmacia, the market leader in comprehensive pharmacy management services to the hospice community, announced today the appointment of Mark Morse as Chief Executive Officer. He will assume day-to-day leadership of Enclara and work in partnership with its current leadership team to help reduce pharmacy costs for hospices, improve patient care, and support caregivers through digital innovation, medication access, clinical care and more.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201014005070/en/

Mark Morse, Chief Executive Officer, Enclara Pharmacia (Photo: Business Wire)

Mark succeeds Andy Horowitz, Enclara founder and CEO, who made plans to move into a strategic advisor role as part of Humana’s acquisition of the pharmacy services provider in February. In the months since, Horowitz has provided direction and leadership throughout the integration process to help bring the two companies together and ensure a smooth transition. He will continue to act as a strategic advisor as

Augury Raises $55 Million Series D Funding to Sustain Rapid Growth, Announces New Global Partnerships and Capabilities

October 14, 2020

| No Comments

| Global Health

New Funding Round Led by Israeli-based Qumra Capital Marks Significant Increase in Valuation for IIoT Leader

Augury, a leading AI-based Machine Health solution provider, today announced it has secured $55 million in funding. The additional capital will be used to sustain and accelerate Augury’s rapid growth and to capitalize on the opportunity to help leading industrial companies improve the reliability, resilience and efficiency of their manufacturing operations. This Series D round was led by Qumra Capital, a leading late-stage venture capital firm based out of Israel. It includes participation from existing key investors, including Insight Venture Partners, Eclipse Ventures, Munich Re Venture Capital, Qualcomm Ventures and Lerer Hippeau Ventures. With this round Augury has raised $106 million since its initial funding six years ago.

The company also announced new partnerships and capabilities to help its global customers gain the benefit of prescriptive diagnostics and machine insights, no matter where in

Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple …

October 14, 2020

| No Comments

| Health Facts

NEWTOWN, Pa., Oct. 14, 2020 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced a partnership with Breakthrough Health (“Breakthrough”), a Berlin-based technology company. Breakthrough builds privacy-focused applications that empower people living with chronic disease to gather and securely own their healthcare data, with the opportunity to share it to support research.

Together, Helius and Breakthrough will work on a research project to better understand how people living with Multiple Sclerosis (“MS”) in the United States evaluate their therapy options as it relates to treatment of gait deficit due to symptoms of MS, which impacts approximately 50-80% of the MS population, estimated at 1,000,000 individuals.

This research project will be conducted via Breakthrough’s MS companion application (“app”) called Emilyn. Emilyn provides Helius with potential access to a diverse cross-section of the MS population, with over

Bloomberg New Economy Forum Announces New Global Co-Hosts and Preliminary Speaker Line-up for 2020 Virtual Event

October 14, 2020

| No Comments

| Global Health

NEW YORK, BEIJING, LONDON and JOHANNESBURG, Oct. 14, 2020 /PRNewswire/ — The China Center for International Economic Exchanges (CCIEE), The International Institute for Strategic Studies (IISS), and Mandela Institute for Development Studies (MINDS) have been named as co-hosts for the 2020 Bloomberg New Economy Forum, to be held virtually November 16-19. More than 500 current and former heads of state, influential business executives, government officials, academics and experts from around the world will join them in a collaborative effort to help redesign key parts of the global economy after the ravages of Covid-19, emphasizing sustainable and inclusive growth.

An overarching goal of this effort is to bring together leaders from East and West to work toward “Our New Economy”— a shared future that reflects the shifting composition of economic forces in the world today. Now in its third year, the Bloomberg New Economy Forum is a unique convening platform

Allegheny Co. Health Dept. Announces 74 New Coronavirus Cases, Bringing Countywide Total To 13,436

October 13, 2020

| No Comments

| Dept Of Health

By: KDKA-TV News Staff

PITTSBURGH (KDKA) — The Allegheny County Health Department is reporting 74 new Coronavirus cases Tuesday and no new deaths.

Of the newly reported cases, 57 are confirmed from 1,301 PCR tests and 17 are probable. Eight of those probable cases are from positive antigen tests.

The total number of cases countywide now stands at 13,436 since March 14.

New cases range in age from 14 years to 91 years with a median age of 35 years, the Health Department says. The dates of positive tests ranged from Oct. 7-12.

There have been 1,293 hospitalizations in Allegheny County since the outbreak began. Of all the hospitalized patients, 329 of them have needed care in the ICU, and 128 of them have required treatment with a ventilator.

The county-wide death toll stands at 397.

This is the COVID-19 Daily Update from the Allegheny County Health Department (ACHD) for

Better Choice Announces Closing of Expanded Series F Financing and Acceleration of Asian Expansion | Money

October 13, 2020

| No Comments

| Health And Wellness

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from

Trxade Group Subsidiary Bonum Health Announces Prescription Savings Partnership with SingleCare

October 13, 2020

| No Comments

| Health Facts

TAMPA, FL, Oct. 13, 2020 (GLOBE NEWSWIRE) — Trxade Group Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its Bonum Health subsidiary has partnered with SingleCare, the prescription savings service, to enhance Bonum’s enterprise telehealth solutions with prescription discounts powered by SingleCare. The enterprise service will be offered to national, regional and local pharmacies to promote the benefit to uninsured patients and underserved communities.

The increasing cost of healthcare has been exacerbated by the economic pressures of COVID-19, especially for the millions of recently unemployed across America. Bonum Health enables convenient access to affordable care with its clinical technology platform and telehealth solutions that offer virtual medical and provider services at deeply discounted rates. Through these telehealth solutions, an entire household can receive a virtual consultation by board-certified medical doctors, anywhere, at any time.

SingleCare is a free prescription savings service that is providing

Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)

October 13, 2020

| No Comments

| Health Facts

Confirmation underscores Moderna’s commitment to make its vaccine available in Canada

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the initiation of a rolling submission to Health Canada for mRNA-1273, the Company’s vaccine candidate against COVID-19. This initiation follows positive results from a preclinical viral challenge study of mRNA-1273 and the positive interim analysis of the Phase 1 study of mRNA-1273 in healthy adults (ages 18-55 years) and older adults (ages 56-70 and 71+) published in the New England Journal of Medicine.

The rolling submission has been accepted under the Canadian Minister of Health’s Interim Order, which permits companies to submit safety and efficacy data and information as they become available. This rolling review process allows Health Canada to begin its assessment using the information submitted by the applicant and accept

Notable Labs Announces Addition of Thomas Bock to Board of Directors

October 13, 2020

| No Comments

| Health

Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced the addition of Dr. Thomas A. Bock to its board of directors.

Bock is a recognized life science leader who built four entrepreneurial organizations that created major impact for both patients and investors, achieving leadership in their fields. He successfully spearheaded new medical paradigms and fast-growing markets such as cancer precision medicine, ultra-rare disorders and cancer prevention.

“We are delighted to welcome Thomas Bock to Notable’s board of directors,” said Laurie Heilmann, Notable CEO. “Thomas’ wealth of experience leading worldwide medical divisions at top-tier pharma organizations such as Novartis, Celgene and Alexion will be of great value to Notable. Thomas developed and commercialized six lifesaving, paradigm-changing blockbuster medicines in cancer, ultra-rare disorders and inflammation. Thomas brings tremendous industry knowledge and experience, which will be instrumental in navigating and supporting Notable’s path

Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis

October 13, 2020

| No Comments

| Health

– Primary endpoint of asthma worsening not met in LEDA Study, however consistent numeric reductions ranging from 32-35% observed across all three GB001 groups –

– Statistically significant improvements in key secondary endpoint of time to first asthma worsening of 28% and 30% observed for 20 mg and 60 mg doses of GB001, respectively; 23% improvement observed in 40 mg group –

– TITAN Study in chronic rhinosinusitis did not meet primary or secondary endpoints –

– Gossamer to hold webcast to discuss trial results at 8:00 am EDT –

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced topline results from its Phase 2b LEDA trial in patients with moderate-to-severe eosinophilic asthma and its Phase 2 TITAN trial in patients with chronic rhinosinusitis.

“While we did not achieve statistical significance

Mediarabe

Tag: announces

Enclara Pharmacia Announces the Appointment of Mark Morse as CEO

Augury Raises $55 Million Series D Funding to Sustain Rapid Growth, Announces New Global Partnerships and Capabilities

Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple …

Bloomberg New Economy Forum Announces New Global Co-Hosts and Preliminary Speaker Line-up for 2020 Virtual Event

Allegheny Co. Health Dept. Announces 74 New Coronavirus Cases, Bringing Countywide Total To 13,436

Better Choice Announces Closing of Expanded Series F Financing and Acceleration of Asian Expansion | Money

Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)

Notable Labs Announces Addition of Thomas Bock to Board of Directors

Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis